
The study examined the 15-year oncological outcomes of 1,807 men with clinically-localized prostate cancer treated with robot-assisted laparoscopic prostatectomy (RALP) between 2001 and 2005. The study found that the 15-year rates of biochemical failure (BCF), metastasis, secondary therapy use, prostate cancer-specific mortality (PCSM), and overall survival (OS) were 28.1%, 4.0%, 16.3%, 2.5%, and 82.1%, respectively. The rates of oncologic failure increased with increasing preoperative and postoperative risk scores. The study concludes that men treated with RALP achieve durable long-term oncological control, and the data reported here should be of value when counseling patients regarding expected oncologic outcomes from RALP.
Like
Save
Share